ABY-029: Clinical Trials

5 trials of ABY-029, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 not yet recruiting, 1 recruiting. 3 Early Phase 1, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 13Completed 3
Phase 12Not yet recruiting 1, Recruiting 1

Follow ABY-029: new trials by email Literature Review of ABY-029 trials Research Report on ABY-029

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ABY-029 Head & Neck Trial
ABY-029 - Head and Neck Squamous Cell Carcinoma
Phase 1Not yet recruitingDartmouth-Hitchcock Medical Center242026-06-302026-05-07
ABY-029 Glioma Trial
ABY-029 - Intracranial Tumor
Phase 1RecruitingDartmouth-Hitchcock Medical Center332026-02-172026-03-10
A Microdose Evaluation Study of ABY-029 in Head and Neck Oncology Surgery
ABY-029 - Head and Neck Cancer
Early Phase 1CompletedDartmouth-Hitchcock Medical Center122018-01-242023-05-18
A Microdose Evaluation Study of ABY-029 in Primary Sarcoma
ABY-029 - Primary Soft-tissue Sarcoma
Early Phase 1CompletedDartmouth-Hitchcock Medical Center122017-08-302021-08-30
A Microdose Evaluation Study of ABY-029 in Recurrent Glioma
ABY-029 - Glioma
Early Phase 1CompletedDartmouth-Hitchcock Medical Center142017-02-132024-12-13

Conditions studied

Brain Neoplasms (1)  ·  Glioma (1)  ·  Head and Neck Neoplasms (1)  ·  Squamous Cell Carcinoma of Head and Neck (1)

Sponsors

Dartmouth-Hitchcock Medical Center (5)

Countries

United States (4)

Top investigators

David W Roberts, MD (1)  ·  Eric R Henderson, MD (1)  ·  Joseph A Paydarfar, MD (1)  ·  Joseph Paydarfar, MD (1)  ·  Linton Evans, MD (1)

NIH funding

R01CA167413 (3)